Successful treatment with infliximab for Behçet disease during pregnancy.
To report a case of successful treatment with infliximab for Behçet disease (BD) during pregnancy. A case report. A 30-year-old woman was diagnosed with BD at 12 weeks of pregnancy. Additional symptoms occurred, and infliximab at a dose of 5 mg/kg body weight was initiated at 18 weeks and repeated. All symptoms improved, and a 3950-g infant was delivered uneventfully without any abnormality at 39 weeks. A few weeks after delivery, uveitis and systemic symptoms relapsed. Infliximab was reinitiated and all symptoms were resolved. Infliximab may be safe and effective for BD during pregnancy.